Adalia Jun-o'connell, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 14 Prospect St, Milford, MA 01757 Phone: 508-381-5016 Fax: 508-381-5035 |
John B. Levine, MD Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 14 Prospect Street, Milford, MA 01757 Phone: 508-482-5444 Fax: 508-482-5408 |
Aditi Ahlawat, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 14 Prospect St, Milford, MA 01757 Phone: 508-473-1190 |
Dr. Christopher Robertson, MD Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Medicare Enrolled Practice Location: 10 Asylum St, Milford, MA 01757 Phone: 617-211-5040 |
Dr. Xiangyang Li, MD, PHD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 229 East Main St Suit #204, Milford, MA 01757 Phone: 508-458-9060 Fax: 508-458-9060 |
Dr. Sunjay Sethi, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 14 Prospect St, Milford, MA 01757 Phone: 508-381-5016 Fax: 508-381-5035 |
Andrew Ferree, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 14 Prospect St, Milford, MA 01757 Phone: 508-381-5016 Fax: 508-381-5035 |
News Archive
New research suggests that chronic traumatic encephalopathy, a brain disease associated with repeat brain trauma including concussions in athletes, may affect people in two major ways: initially affecting behavior or mood or initially affecting memory and thinking abilities.
AIDS Healthcare Foundation (AHF) , which operates the largest community-based alternative HIV and sexually transmitted disease (STD) testing program in California, has launched an innovative and eye-catching Los Angeles-area HIV prevention and testing campaign urging the public to "Stay Negative" and to visit www.freehivtest.net to find out where to get tested quickly, conveniently and at no cost.
Cancer cells can develop resistance to therapy through both genetic and non-genetic mechanisms. But it is unclear how and why one of these routes to resistance prevails.
A diabetes drug that showed promise in previous studies as an anti-cancer treatment failed to show any benefit in a UNC Lineberger Comprehensive Cancer Center-led study that used pancreatic cancer tissue samples to test sensitivity to the drug.
Santarus, and Depomed, today announced that supply of GLUMETZA® 500 mg to wholesalers and retailers has resumed. GLUMETZA is a once-daily, extended release formulation of metformin and is approved for use in adults with type 2 diabetes mellitus.
› Verified 9 days ago